Gut bacteria and body response in liver disease
Part of Digestive system clinical trials.
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed liver disease, confirmed by your doctor.
- You are between 18 and 70 years old.
- You can understand English well enough to read or talk about the study.
- You have not taken antibiotics, steroids, or immune-suppressing drugs in the last month.
- You are not pregnant or breastfeeding.
- You do not have other active gut diseases like Crohn's, colitis, or irritable bowel syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
This study looks at the gut microbiome (the bacteria in your digestive system) in people living with HIV or hepatitis B. By comparing stool samples, researchers hope to understand how these viruses affect gut health, which might lead to better care.
This trial studies how the gut (your digestive system) affects how well immunotherapy works for advanced liver cancer. You'll have a colonoscopy (a test to look inside your bowel) and provide samples, which could help doctors improve treatment for you and others.
This study looks at the bacteria in the gut of people with liver cirrhosis to better understand how they relate to the disease. By joining, you help researchers learn more about cirrhosis, which may lead to better care in the future.
This study looks at how the bacteria in your gut (microbiome) affect liver cancer treatment. It aims to learn if certain gut bacteria can predict how well the combination of targeted therapy and immunotherapy works.
This study looks at how gut bacteria change in people with liver cirrhosis and whether these changes relate to how the disease progresses. It may help find new ways to monitor or treat cirrhosis.
Hear when a new Gut Microbiome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.